These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 29098838)
1. [Oral absorption of asiatic acid nanoparticles modified with PEG]. Zhang YW; Yin LN; Huang XY; Liang ZH; Chen XX; Wang SH Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(14):2784-2788. PubMed ID: 29098838 [TBL] [Abstract][Full Text] [Related]
2. [Response surface method for optimization of asiatic acid nanoparticles modified with PEG and its enhancing effects on intestinal absorption]. Huang XY; Zhang YW; Yin LN; Liang ZH; Zhu L; Wang SH Zhongguo Zhong Yao Za Zhi; 2016 Sep; 41(17):3239-3243. PubMed ID: 28920376 [TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects. Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288 [TBL] [Abstract][Full Text] [Related]
4. Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis. Zhang YW; Tu LL; Zhang Y; Pan JC; Zheng GL; Yin LN Drug Deliv; 2021 Dec; 28(1):2534-2547. PubMed ID: 34854788 [TBL] [Abstract][Full Text] [Related]
5. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Zhang S; Wang J; Pan J Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105 [TBL] [Abstract][Full Text] [Related]
6. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery. Li H; Chen M; Su Z; Sun M; Ping Q Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421 [TBL] [Abstract][Full Text] [Related]
7. PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A. Wang L; Luo Q; Lin T; Li R; Zhu T; Zhou K; Ji Z; Song J; Jia B; Zhang C; Chen W; Zhu G Drug Dev Ind Pharm; 2015; 41(7):1204-12. PubMed ID: 25010850 [TBL] [Abstract][Full Text] [Related]
8. [Preparation of PEG-modified nanostructured lipid carriers loaded with hydroxycamptothecin and tissue distribution in mice]. Zhang XX; Gan Y; Yang XG; Zhu CL; Gan L; Nie SF; Pan WS Yao Xue Xue Bao; 2008 Jan; 43(1):91-6. PubMed ID: 18357740 [TBL] [Abstract][Full Text] [Related]
9. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]
10. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles. Lingling G; Yuan Z; Weigen L Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124 [TBL] [Abstract][Full Text] [Related]
11. Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Liu X; Zhang Z; Jiang Y; Hu Y; Wang Z; Liu J; Feng R; Zhang J; Huang G Drug Deliv; 2015 Feb; 22(2):223-9. PubMed ID: 24559497 [TBL] [Abstract][Full Text] [Related]
12. Magnesium lithospermate B loaded PEGylated solid lipid nanoparticles for improved oral bioavailability. Kang X; Chen H; Li S; Jie L; Hu J; Wang X; Qi J; Ying X; Du Y Colloids Surf B Biointerfaces; 2018 Jan; 161():597-605. PubMed ID: 29156336 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers. Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003 [TBL] [Abstract][Full Text] [Related]
14. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405 [TBL] [Abstract][Full Text] [Related]
15. Construction and in vitro/in vivo evaluation of 17-allylamino-17-demethoxygeldanamycin (17AAG)-loaded PEGylated nanostructured lipid carriers. Wang Z; Wang J; Yang S; Hou S Drug Dev Ind Pharm; 2016 Jan; 42(1):91-98. PubMed ID: 25853294 [TBL] [Abstract][Full Text] [Related]
16. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Ji H; Tang J; Li M; Ren J; Zheng N; Wu L Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt-emulsification. Yuan H; Wang LL; Du YZ; You J; Hu FQ; Zeng S Colloids Surf B Biointerfaces; 2007 Nov; 60(2):174-9. PubMed ID: 17656075 [TBL] [Abstract][Full Text] [Related]
18. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol. Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044 [TBL] [Abstract][Full Text] [Related]
20. Core-matched encapsulation of an oleate prodrug into nanostructured lipid carriers with high drug loading capability to facilitate the oral delivery of docetaxel. Sun B; Luo C; Li L; Wang M; Du Y; Di D; Zhang D; Ren G; Pan X; Fu Q; Sun J; He Z Colloids Surf B Biointerfaces; 2016 Jul; 143():47-55. PubMed ID: 27011346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]